Evotec (ETR:EVT) said today that it inked a 5-year drug discovery and development deal with Celgene (NSDQ:CELG) to identify stem cell therapies for a range of neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease. According to the agreement, Hamburg, Germany-based Evotec will receive an upfront payment of $45 million and Celgene will hold exclusive […]
Distribution
Senseonics, Roche expand distribution deal for Eversense glucose monitor
Senseonics (NYSE:SENS) said today that it expanded its exclusive distribution agreement with Roche (PINK:RHHBY) for its implantable continuous glucose monitoring system for people with diabetes. The new agreement includes all of Europe, the Middle East and Africa, excluding Scandinavia, Finland and Israel. According to the agreement, Germantown, Maryland-based Senseonics has given Roche exclusive rights to promote, […]
Adhezion Biomedical, Pfizer ink long-term supply deal
Adhezion Biomedical announced today that it inked a long-term supply deal with Pfizer (NYSE:PFE) for exclusive U.S. distribution rights for Adhezion’s topical skin adhesives. The Wyomissing, Pa.-based medical device company has a product family of 2-octyl cyanoacrylate adhesives designed to hold the edges of skin wounds together, for use after minimally invasive surgery and simple […]
